{
  "study_metadata": {
    "design": "RCT",
    "species": "Homo sapiens",
    "n_total": 29,
    "country": "United States",
    "setting": "outpatient",
    "population": "nonobese postmenopausal women with normal glucose tolerance",
    "inclusion_key": "normal glucose tolerance",
    "exclusion_key": null,
    "mean_age": 59.0,
    "female_pct": 100.0,
    "diabetes_status": "other",
    "primary_outcome": "HOMA_IR"
  },
  "intervention": {
    "agent": "resveratrol",
    "form": "capsule",
    "dose_mg_per_day": 75.0,
    "duration_weeks": 12.0,
    "cointerventions": null
  },
  "comparison": {
    "type": "placebo",
    "description": "placebo capsules"
  },
  "arms": [
    {
      "name": "resveratrol",
      "n": 15,
      "dose_mg_per_day": 75.0,
      "duration_weeks": 12.0
    },
    {
      "name": "placebo",
      "n": 14,
      "dose_mg_per_day": 0.0,
      "duration_weeks": 12.0
    }
  ],
  "outcomes_raw": [
    {
      "name": "HOMA_IR",
      "timepoint_weeks": 12.0,
      "arm_name": "resveratrol",
      "baseline_mean": null,
      "baseline_sd": null,
      "followup_mean": null,
      "followup_sd": null,
      "change_mean": null,
      "change_sd": null,
      "units": "HOMA_units",
      "notes": "no change reported"
    },
    {
      "name": "HOMA_IR",
      "timepoint_weeks": 12.0,
      "arm_name": "placebo",
      "baseline_mean": null,
      "baseline_sd": null,
      "followup_mean": null,
      "followup_sd": null,
      "change_mean": null,
      "change_sd": null,
      "units": "HOMA_units",
      "notes": "no change reported"
    }
  ],
  "effects_by_outcome": [
    {
      "name": "HOMA_IR",
      "type": "MD",
      "timepoint_weeks": 12.0,
      "estimate": null,
      "ci_low": null,
      "ci_high": null,
      "p_value": null,
      "adjusted": "false",
      "model_notes": "no significant difference"
    }
  ],
  "risk_of_bias": {
    "randomization_process": null,
    "deviations_from_intended": null,
    "missing_outcome_data": null,
    "measurement_of_outcome": null,
    "selection_of_reported_result": null,
    "overall": null
  },
  "effect": {
    "type": null,
    "estimate": null,
    "ci_low": null,
    "ci_high": null,
    "p_value": null
  },
  "where_found": [
    {
      "section": "results",
      "page": null
    }
  ],
  "evidence": [
    {
      "section": "summary",
      "page": null,
      "snippet": "randomized, double-blind, placebo-controlled trial of 12 weeks of 75 mg/day resveratrol in nonobese postmenopausal women"
    },
    {
      "section": "methods",
      "page": null,
      "snippet": "75 mg/day resveratrol (99% pure trans-resveratrol) for 12 weeks"
    },
    {
      "section": "results",
      "page": null,
      "snippet": "HOMA-IR score did not change after resveratrol supplementation"
    }
  ],
  "missing_fields": [
    "study_metadata.exclusion_key",
    "intervention.cointerventions",
    "comparison.description",
    "outcomes_raw.baseline_mean",
    "outcomes_raw.baseline_sd",
    "outcomes_raw.followup_mean",
    "outcomes_raw.followup_sd",
    "outcomes_raw.change_mean",
    "outcomes_raw.change_sd",
    "risk_of_bias.*",
    "effect.*",
    "where_found.page"
  ],
  "confidence": 0.7,
  "comment": "Data limited to summary; numeric outcomes missing",
  "comment_detailed": "I searched the abstract, methods, and results sections for study design, population, dose, duration, and outcome reporting. The article states a randomized, double-blind, placebo-controlled trial of 75 mg/day resveratrol for 12 weeks in nonobese postmenopausal women with normal glucose tolerance. Baseline and follow-up HOMA-IR values are not provided in the text; only that they did not change. Therefore, numeric outcome fields are set to null. Risk of bias and overall effect estimates cannot be derived from the available text. Full tables or supplementary material would provide the missing means, SDs, and confidence intervals. Page numbers are unavailable, so they are set to null. Confidence is moderate due to limited data. "
}